NovoCure (NVCR) Share-based Compensation (QoQ) (2014 - 2026)
NovoCure (NVCR) Share-based Compensation (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | NovoCure | 2.28 Bn | 1.85 Bn | 142.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -73.00% |
| Mar 31, 2026 | 217.97% |
| Dec 31, 2025 | -32.42% |
| Sep 30, 2025 | 12.16% |
| Jun 30, 2025 | -11.54% |
| Mar 31, 2025 | -52.91% |
| Dec 31, 2024 | 100.09% |
| Sep 30, 2024 | -1.46% |
| Jun 30, 2024 | -6.61% |
| Mar 31, 2024 | 95.46% |
| Dec 31, 2023 | -33.81% |
| Sep 30, 2023 | -19.53% |
| Jun 30, 2023 | -16.23% |
| Mar 31, 2023 | 31.23% |
| Dec 31, 2022 | 13.22% |
| Sep 30, 2022 | 1.87% |
| Jun 30, 2022 | 3.11% |
| Mar 31, 2022 | 11.82% |
| Dec 31, 2021 | -13.04% |
| Sep 30, 2021 | -7.61% |